Alise S. Reicin's Insider Trades & SAST Disclosures
Alise S. Reicin's most recent trade in Tectonic Therapeutic Inc. was a trade of 101,953 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alise S. Reicin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 101,953 | 101,953 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 36,047 | 214,344 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 11,717 | 178,297 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 6,000 | 6,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 289,600 | 289,600 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 166,580 | 166,580 | - | - | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 124,530 | 124,530 | - | - | Common Stock | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 33,923 | 33,923 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,380 | 23,380 | - | - | Employee Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 23,000 | 23,000 | - | - | Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Sana Biotechnology Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 11,795 | 11,795 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges